+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "HPV Vaccine"

Human Papillomavirus (HPV) Vaccine Global Market Report 2024 - Product Thumbnail Image

Human Papillomavirus (HPV) Vaccine Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
From
From
From
Cervical Cancer Vaccine Global Market Report 2024 - Product Thumbnail Image

Cervical Cancer Vaccine Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Cancer Vaccines Global Market Report 2024 - Product Thumbnail Image

Cancer Vaccines Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
From
From
From
From
From
Global Cancer Vaccine Market & Clinical Trials Outlook 2028 - Product Thumbnail Image

Global Cancer Vaccine Market & Clinical Trials Outlook 2028

  • Report
  • July 2022
  • 600 Pages
  • Global
From
Cancer Vaccines: Technologies and Global Markets 2021-2026 - Product Thumbnail Image

Cancer Vaccines: Technologies and Global Markets 2021-2026

  • Report
  • July 2021
  • 155 Pages
  • Global
From
From
From
Loading Indicator

The HPV Vaccine is a type of cancer vaccine used to prevent infection from the human papillomavirus (HPV). HPV is a virus that can cause cervical cancer, as well as other types of cancer. The HPV Vaccine is typically administered to adolescents and young adults, and is recommended by the World Health Organization (WHO) as part of routine immunization programs. The vaccine is available in both a bivalent and quadrivalent form, and is designed to protect against the two most common types of HPV that cause cervical cancer. The HPV Vaccine market is a rapidly growing segment of the cancer vaccine market. It is estimated that the global HPV Vaccine market will reach $4.5 billion by 2027, driven by increasing awareness of the virus and its associated health risks, as well as the availability of the vaccine in many countries. Some of the major companies in the HPV Vaccine market include Merck & Co., GlaxoSmithKline, Sanofi Pasteur, Pfizer, and CSL. Show Less Read more